Compound Evidence File
#EC-2026-0106
BAM15
Filed under Oral Tablets. The bureau holds 171 laboratory returns for this compound from 67 distinct subjects. Scores below are per-subject aggregates; open a subject row for the underlying evidence.
Cross-Index
Subjects Shipping This Compound
67 SUBJECTS| Subject | Grade | Samples | Mean | Min | Max | First seen | Last seen |
|---|---|---|---|---|---|---|---|
| HomopeptideCASE #VI-2026-0760 | A | 5 | 10.0 | 9.9 | 10.0 | 25 May 2026 | 25 May 2026 |
| Tianjin Finder Chemical TFCCASE #VI-2026-0693 | A | 4 | 10.0 | 9.9 | 10.0 | 14 Nov 2025 | 16 Apr 2026 |
| Shanghai ERP BiotechnologyCASE #VI-2026-0936 | A | 4 | 10.0 | 10.0 | 10.0 | 6 Jun 2026 | 5 Jul 2026 |
| BachemCASE #VI-2026-0314 | A | 4 | 10.0 | 10.0 | 10.0 | 12 Dec 2025 | 14 Jun 2026 |
| Hubei JianxiangCASE #VI-2026-0048 | A | 4 | 10.0 | 9.9 | 10.0 | 15 Dec 2025 | 20 Jun 2026 |
| Hybio PharmaceuticalCASE #VI-2026-0065 | A | 4 | 10.0 | 9.9 | 10.0 | 1 Feb 2026 | 10 Aug 2026 |
| QYAOBIOCASE #VI-2026-0861 | A | 3 | 10.0 | 9.9 | 10.0 | 9 Mar 2026 | 27 Jun 2026 |
| Kerui PeptidesCASE #VI-2026-0626 | A | 3 | 10.0 | 9.9 | 10.0 | 1 May 2026 | 16 Jun 2026 |
| Flourishglobal PeptideCASE #VI-2026-0630 | A | 3 | 10.0 | 10.0 | 10.0 | 3 May 2026 | 15 Jul 2026 |
| Thermo Fisher ScientificCASE #VI-2026-0142 | A | 3 | 10.0 | 9.9 | 10.0 | 7 Feb 2026 | 20 Jun 2026 |
| PolyPeptide GroupCASE #VI-2026-0143 | A | 2 | 10.0 | 10.0 | 10.0 | 3 Jul 2026 | 12 Aug 2026 |
| Quenna PMQCASE #VI-2026-0415 | X | 1 | 10.0 | 10.0 | 10.0 | 13 Jun 2025 | 13 Jun 2025 |
| Sangon BioCASE #VI-2026-0671 | A | 4 | 9.9 | 9.9 | 10.0 | 4 Mar 2026 | 1 Jun 2026 |
| JEEP PeptidesCASE #VI-2026-0457 | A | 4 | 9.9 | 9.9 | 10.0 | 18 Feb 2026 | 12 Jul 2026 |
| Shanghai Wibson BiotechnologyCASE #VI-2026-0379 | A | 4 | 9.9 | 9.9 | 10.0 | 14 Mar 2026 | 5 Jul 2026 |
| Shanghai Sigma AudleyCASE #VI-2026-0505 | A | 4 | 9.9 | 9.9 | 10.0 | 24 Apr 2026 | 27 Jun 2026 |
| WuXi TIDESCASE #VI-2026-0335 | A | 4 | 9.9 | 9.9 | 10.0 | 25 Feb 2026 | 9 Jul 2026 |
| AmbioPharmCASE #VI-2026-0177 | A | 4 | 9.9 | 9.9 | 10.0 | 19 Feb 2026 | 9 Aug 2026 |
| Chinese Peptide CompanyCASE #VI-2026-0184 | A | 3 | 9.9 | 9.9 | 10.0 | 18 Jan 2026 | 10 Jul 2026 |
| Sigma-AldrichCASE #VI-2026-0829 | A | 3 | 9.9 | 9.9 | 10.0 | 10 May 2026 | 24 Jun 2026 |
| Mokemei BiotechnologyCASE #VI-2026-0540 | A | 2 | 9.9 | 9.9 | 9.9 | 18 Apr 2026 | 14 Jun 2026 |
| GenScript PeptidesCASE #VI-2026-0860 | A | 2 | 9.9 | 9.9 | 10.0 | 9 Feb 2026 | 9 Mar 2026 |
| SinoPepCASE #VI-2026-0387 | A | 2 | 9.9 | 9.9 | 10.0 | 13 Mar 2026 | 23 May 2026 |
| AsymchemCASE #VI-2026-0091 | A | 2 | 9.9 | 9.9 | 10.0 | 3 Jun 2026 | 20 Jul 2026 |
| Shanghai Sigma Audley SSACASE #VI-2026-0486 | A | 5 | 9.2 | 8.1 | 9.8 | 24 May 2026 | 24 May 2026 |
| LSPLCASE #VI-2026-0523 | X | 1 | 9.0 | 9.0 | 9.0 | 11 Jun 2025 | 11 Jun 2025 |
| Glbiochem (Shanghai)CASE #VI-2026-0704 | A | 6 | 8.8 | 8.6 | 9.0 | 23 May 2026 | 23 May 2026 |
| Nantong Guangyuan Chemical GYCCASE #VI-2026-0284 | A | 3 | 8.6 | 7.5 | 9.8 | 24 May 2026 | 24 May 2026 |
| Wuhan Wansheng Bio (WWB)CASE #VI-2026-0594 | A | 4 | 8.3 | 7.2 | 9.5 | 23 May 2026 | 23 May 2026 |
| Bfflist AMOCASE #VI-2026-0678 | X | 4 | 8.2 | 7.0 | 9.8 | 3 Jul 2025 | 25 May 2026 |
| Yongkang Nuoao Trading CoCASE #VI-2026-0646 | X | 1 | 8.2 | 8.2 | 8.2 | 17 Dec 2024 | 17 Dec 2024 |
| Qingdao Sigma Chemical QSCCASE #VI-2026-0538 | A | 4 | 8.0 | 6.9 | 9.0 | 25 May 2026 | 25 May 2026 |
| Limitless Life NootropicsCASE #VI-2026-0980 | X | 2 | 7.7 | 7.0 | 8.3 | 24 Apr 2025 | 23 May 2026 |
| Shanghai Wibson Biotechnology WBSCASE #VI-2026-0214 | X | 1 | 7.5 | 7.5 | 7.5 | 2 Apr 2025 | 2 Apr 2025 |
| Astro PeptidesCASE #VI-2026-0424 | X | 1 | 7.5 | 7.5 | 7.5 | 25 Apr 2025 | 25 Apr 2025 |
| UtherCASE #VI-2026-0902 | X | 6 | 7.2 | 6.0 | 9.6 | 7 May 2025 | 24 May 2026 |
| Alimo PeptideCASE #VI-2026-0524 | X | 1 | 7.2 | 7.2 | 7.2 | 8 Jul 2025 | 8 Jul 2025 |
| Shanghai JinBei Chemical TechnologyCASE #VI-2026-0107 | X | 1 | 7.2 | 7.2 | 7.2 | 3 Jul 2025 | 3 Jul 2025 |
| Orbitrex PeptidesCASE #VI-2026-0812 | X | 1 | 7.2 | 7.2 | 7.2 | 13 Jun 2025 | 13 Jun 2025 |
| Atomik LabzCASE #VI-2026-0327 | X | 4 | 7.1 | 4.4 | 9.3 | 27 Feb 2025 | 25 May 2026 |
| HkRoidsCASE #VI-2026-0784 | X | 1 | 7.1 | 7.1 | 7.1 | 13 Feb 2025 | 13 Feb 2025 |
| PeptidologyCASE #VI-2026-0520 | X | 1 | 7.1 | 7.1 | 7.1 | 17 Dec 2024 | 17 Dec 2024 |
| Dankang BioHealthCASE #VI-2026-0775 | X | 1 | 7.0 | 7.0 | 7.0 | 16 Mar 2025 | 16 Mar 2025 |
| NexaphCASE #VI-2026-0944 | X | 9 | 6.9 | 4.6 | 9.2 | 16 Mar 2025 | 26 Jan 2026 |
| Xingtai Jiachuang TechnologyCASE #VI-2026-0712 | X | 1 | 6.8 | 6.8 | 6.8 | 13 Jun 2025 | 13 Jun 2025 |
| SRY LabsCASE #VI-2026-0657 | X | 7 | 6.7 | 5.1 | 8.0 | 25 Apr 2025 | 21 May 2026 |
| Hunan Ruiwang Technology CenterCASE #VI-2026-0027 | X | 1 | 6.7 | 6.7 | 6.7 | 17 Dec 2024 | 17 Dec 2024 |
| Polaris PeptidesCASE #VI-2026-0839 | X | 3 | 6.6 | 5.2 | 7.6 | 2 Jul 2025 | 19 Jan 2026 |
| Xingtai Lesda TechnologyCASE #VI-2026-0381 | X | 1 | 6.5 | 6.5 | 6.5 | 6 May 2025 | 6 May 2025 |
| Simple PeptideCASE #VI-2026-0782 | X | 2 | 6.3 | 4.1 | 8.5 | 16 Mar 2025 | 20 May 2026 |
| Xingtai Pukelai Technology CoCASE #VI-2026-0850 | X | 1 | 6.3 | 6.3 | 6.3 | 16 Mar 2025 | 16 Mar 2025 |
| Xianhong Tong XHT PeptidesCASE #VI-2026-0997 | X | 1 | 6.0 | 6.0 | 6.0 | 11 Jun 2025 | 11 Jun 2025 |
| Modern AminosCASE #VI-2026-0635 | X | 1 | 5.9 | 5.9 | 5.9 | 21 May 2025 | 21 May 2025 |
| Zen PeptidesCASE #VI-2026-0940 | X | 1 | 5.9 | 5.9 | 5.9 | 2 Jul 2025 | 2 Jul 2025 |
| Verified PeptidesCASE #VI-2026-0407 | X | 3 | 5.2 | 3.8 | 6.3 | 25 Apr 2025 | 23 May 2026 |
| SubQ SocietyCASE #VI-2026-0716 | X | 1 | 5.1 | 5.1 | 5.1 | 3 Jul 2025 | 3 Jul 2025 |
| Richards Biotech Simply RichardsCASE #VI-2026-0307 | X | 1 | 4.9 | 4.9 | 4.9 | 21 May 2025 | 21 May 2025 |
| Suaway Lab ResearchCASE #VI-2026-0488 | X | 3 | 4.7 | 3.9 | 5.1 | 14 Jan 2025 | 21 May 2026 |
| Wolverine PeptidesCASE #VI-2026-0262 | X | 1 | 4.5 | 4.5 | 4.5 | 9 Jun 2025 | 9 Jun 2025 |
| Shandong Nuoweiou Medical Technology CoCASE #VI-2026-0076 | X | 1 | 4.3 | 4.3 | 4.3 | 8 Jul 2025 | 8 Jul 2025 |
| TydesCASE #VI-2026-0493 | X | 1 | 3.9 | 3.9 | 3.9 | 11 Jun 2025 | 11 Jun 2025 |
| DeuschemCASE #VI-2026-0004 | X | 1 | 3.1 | 3.1 | 3.1 | 14 Jan 2025 | 14 Jan 2025 |
| Swiss ChemsCASE #VI-2026-0030 | X | 1 | 2.8 | 2.8 | 2.8 | 20 Jun 2025 | 20 Jun 2025 |
| Hebei Chengtong TechnologyCASE #VI-2026-0520 | X | 1 | 1.3 | 1.3 | 1.3 | 2 Jul 2025 | 2 Jul 2025 |
| Weifang Xingbei International TradeCASE #VI-2026-0766 | X | 1 | 1.1 | 1.1 | 1.1 | 28 Mar 2025 | 28 Mar 2025 |
| NuLife PeptidesCASE #VI-2026-0980 | X | 1 | 0.4 | 0.4 | 0.4 | 24 Apr 2025 | 24 Apr 2025 |
| PepKitsCASE #VI-2026-0320 | X | 1 | 0.0 | 0.0 | 0.0 | 21 May 2025 | 21 May 2025 |
Open any subject to view the batch-level evidence for BAM15 alone.